Ptc Therapeutics (PTCT) Operating Expenses (2012 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Operating Expenses of $211.5 million for Q2 2026, down 1.07% year-over-year from $213.8 million in Q2 2025, and down 7.05% quarter-over-quarter from $227.6 million in Q1 2026.
Ptc Therapeutics (PTCT) Operating Expenses (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Operating Expenses history runs 15 years deep, the most recent figure standing at $211.5 million for Q2 2026.
- In Q2 2026, Operating Expenses fell 1.07% year-over-year to $211.5 million; the TTM figure through Jun 2026 stood at $883.2 million (down 15.61% YoY), while the FY2025 annual figure was $863.7 million, down 22.14% from the prior year.
- Operating Expenses for Q2 2026 stood at $211.5 million, down from $227.6 million in the prior quarter.
- The five-year high for Operating Expenses was $423.4 million in Q2 2023, with the low at $205.9 million in Q1 2025.
- The 5-year median for Operating Expenses is $253.4 million (2024), against an average of $274.2 million.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses jumped 64.16% in 2023, then sank 46.4% in 2024.
- Ptc Therapeutics' Operating Expenses stood at $367.8 million in 2022, then decreased by 18.09% to $301.2 million in 2023, then climbed by 24.67% to $375.6 million in 2024, then slumped by 37.15% to $236.0 million in 2025, then dropped by 10.37% to $211.5 million in 2026.
- Business Quant data shows PTCT's Operating Expenses at $211.5 million in Q2 2026, $227.6 million in Q1 2026, and $236.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | 211.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 211.54 Mn |
| Mar 31, 2026 | 227.59 Mn |
| Dec 31, 2025 | 236.03 Mn |
| Sep 30, 2025 | 207.99 Mn |
| Jun 30, 2025 | 213.83 Mn |
| Mar 31, 2025 | 205.87 Mn |
| Dec 31, 2024 | 375.56 Mn |
| Sep 30, 2024 | 251.30 Mn |
| Jun 30, 2024 | 226.92 Mn |
| Mar 31, 2024 | 255.57 Mn |
| Dec 31, 2023 | 301.24 Mn |
| Sep 30, 2023 | 314.74 Mn |
| Jun 30, 2023 | 423.35 Mn |
| Mar 31, 2023 | 338.00 Mn |
| Dec 31, 2022 | 367.75 Mn |
| Sep 30, 2022 | 285.31 Mn |
| Jun 30, 2022 | 257.89 Mn |
| Mar 31, 2022 | 235.26 Mn |
| Dec 31, 2021 | 249.96 Mn |
| Sep 30, 2021 | 231.82 Mn |